The Brown University Oncology Group is a clinical research site located in Providence, Rhode Island, United States 02903.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
The Brown University Oncology Group has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Brown University Oncology Group has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Brown University Oncology Group has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.
The Brown University Oncology Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.